14 March 2020 0 6K Report

When we injected therapeutic lentivirus to a human cell in vivo, then lentivirus infects host cells, meanwhile leave VSV-G and p26 protein on the surface of infected cells, whether host immune cell recognize viral proteins, then immune system kills cells with VSV-G and p26 that are infected by lentivirus.

In this way, in vivo lentivirus therapy is nearly less effective, because the immune cell will clean infected cells?

More Wei Li's questions See All
Similar questions and discussions